LINC00824: A Potential Drug Target for various diseases (G101927774)

Target Name: LINC00824

NCBI ID: G101927774

Other Name(s): LINC01263 | long intergenic non-protein coding RNA 824 | Long intergenic non-protein coding RNA 824, transcript variant 1

LINC00824: A Potential Drug Target for various diseases

LINC00824 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of cell growth and differentiation, and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the defining features of LINC00824 is its ability to interact with a protein called T-cell receptor alpha chain (TCR?±), which is a critical regulator of T-cell development and function. LINC00824 has been shown to physically interact with TCR?±, and this interaction is critical for the proper function of T cells.

In addition to its role in T-cell biology, LINC00824 has also been shown to play a key role in the regulation of cell growth and differentiation. It has been shown to promote the growth of various types of cells, including cancer cells, and to play a role in the development of neurodegenerative diseases.

The search for potential drug targets and biomarkers for LINC00824 has led to the identification of a number of potential targets. One of the most promising targets is the protein called CD90, which is a cell adhesion molecule that is expressed in various tissues of the body.

Studies have shown that LINC00824 physically interacts with CD90, and that this interaction is critical for the proper function of CD90. This suggests that CD90 may be a useful target for LINC00824, and that it may be a potential drug target for various diseases.

Another potential target for LINC00824 is the protein called NF-kappa-B, which is a signaling molecule that plays a role in the regulation of inflammation and immune responses. LINC00824 has been shown to physically interact with NF-kappa-B, and that this interaction is critical for the proper function of NF-kappa-B.

This suggests that NF-kappa-B may be a useful target for LINC00824, and that it may be a potential drug target for various diseases.

In conclusion, LINC00824 is a protein that has been shown to play a key role in the regulation of cell growth and differentiation, and has been implicated in a number of diseases. The interaction between LINC00824 and TCR?±, as well as its ability to promote the growth of various types of cells, make it a promising target for drug development. The identification of potential targets, such as CD90 and NF-kappa-B, further supports the potential of LINC00824 as a drug target for various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 824

More Common Targets